Replies to post #38430 on Intellipharmaceutics International Inc. (IPCI)

[TheFinalCD]

lol whats wrong with them?

[chainma1l]

And the market is $279 million for all strengths. They have 50mg and 100mg. What are they going to get, .5% MAYBE? Hasn't Mallinckrodt done next to nothing for them so far?
May be a good time to get out for anyone left holding this bag if there is any kind of bump in the pps.
What a joke.

The Company is aware that several other generic versions of this product are currently available that serve to limit the overall market opportunity for this product. There can be no assurance that the Company's desvenlafaxine extended-release tablets in the 50 or 100 mg strengths will receive final FDA approval or, if approved, that they will be successfully commercialized and produce significant revenue for us.